MergerMay 15, 2026, 08:26 AM
Pulmatrix to Merge with Eos SENOLYTIX; Q1 Net Loss $(1.17)M
AI Summary
Pulmatrix, Inc. announced a definitive merger agreement with Eos SENOLYTIX, Inc., under which Eos stockholders will own approximately 94% of the combined company, and Pulmatrix stockholders will own approximately 6%. Concurrently, Pulmatrix received a $1.0 million investment as part of a larger $19 million aggregate financing. For Q1 2026, the company reported a net loss of $(1.17) million, an improvement from $(1.81) million in Q1 2025, but faces substantial doubt about its ability to continue as a going concern without the merger.
Key Highlights
- Entered Merger Agreement with Eos SENOLYTIX, Inc. on March 26, 2026.
- Pre-Merger Eos stockholders to own approximately 94% of the combined company.
- Pulmatrix stockholders to own approximately 6% of the combined company on a fully-diluted basis.
- Received $1.0 million investment in Series B Convertible Preferred Stock as part of $19 million aggregate financing.
- Q1 2026 net loss was $(1.17) million, an improvement from $(1.81) million in Q1 2025.
- Cash and cash equivalents were $3.32 million as of March 31, 2026.
- Net cash used in operating activities was $(1.07) million for the three months ended March 31, 2026.
- Company faces substantial doubt about its ability to continue as a going concern without the merger.
Price Impact
More from PULM